Singapore markets closed

Pharma Equity Group A/S (PEGC.XC)

Cboe UK - Cboe UK Real-time price. Currency in DKK
Add to watchlist
1.9950-1.9950 (-100.00%)
As of 08:04AM BST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Cost of revenue
0
0
0
-
-
-
Gross profit
0
0
0
-
-
0
Operating expenses
Research development
10,932
9,082
5,497
-
-
-
Selling general and administrative
13,583
11,809
5,780
1,444
2,135
-
Total operating expenses
28,918
25,294
11,277
-56
12,135
-
Operating income or loss
-28,918
-25,294
-11,277
56
-12,135
-
Interest expense
2,516
1,562
22
665
272
-
Income before tax
-31,419
-26,841
-11,299
5,392
-32,875
-
Income tax expense
-2,313
-2,233
-1,855
0
0
-
Income from continuing operations
-29,106
-24,608
-9,444
5,392
-32,875
-
Net income
-29,107
-24,609
-9,444
5,392
-32,875
-
Net income available to common shareholders
-29,107
-24,609
-9,444
5,392
-32,875
-
Basic EPS
0.10
-0.02
-0.01
0.10
-1.03
-
Diluted EPS
0.08
-0.02
-0.01
0.10
-1.03
-
Basic average shares
76,122
1,080,360
953,972
55,571
31,805
-
Diluted average shares
76,122
1,088,551
977,348
58,256
31,805
-